Connect with us

Cannabis News

Alabama Officials Approve Medical Marijuana Dispensary Licenses, Readying Program For Sales To Start In 2026

Published

on

“I’m absolutely delighted today that we’re on the verge of having a work programme.”

By Anna Barrett, Alabama Reflector

The Alabama Medical Cannabis Board on Thursday approved three dispensary licenses in what board members called a critical step. making medical cannabis available in Alabama Almost five years after the legislature enacted the program.

“We’ve waited a long time to get to this point where we can make a decision like this, and it’s monumental,” said board chairman Rex Vaughn. “It’s a milestone for us, so I’m excited we can get this far.”

GP6 Wellness, RJK Holdings and CCS will receive Alabama dispensary licenses within 28 days, as long as the companies pay a $40,000 licensing fee. A fourth license will be approved by the board in late January based on a recommendation from an administrative law judge, Vaughn said after the meeting.

Vaughn said several times at the meeting that the approval of the dispensary licenses is a milestone and will provide the care patients need and tax revenue for the state.

“It takes time to get through the system, but we should be seeing revenue by spring at the latest,” Vaughn said.

Alabama’s cannabis law, passed in 2021, allows registered doctors to prescribe cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s disease, PTSD, sickle cell anemia, chronic pain and terminal illnesses. Acceptable product forms are limited to tablets, tinctures, patches, oils, and gummies (peach flavor only), herbal raw materials and smoking forms are prohibited.

People suffering from the conditions must obtain a doctor’s authorization and enter the patient registry to purchase products at a pharmacy.

Lawsuits have also hindered access to medical cannabis. Some companies sued the commission for not issuing licenses, citing a discriminatory process. In another case there were five Parents sued the board over delays in accessing cannabiswhich was released in August.

As of Thursday, the commission has issued licenses to nine growers, four processors, four transporters and three dispensaries. There is also a patient on the registry, Vaughn said.

Vaughn could not provide a specific timeline for when the product will be available for purchase, but estimated spring 2026. Earlier this year, AMCC Executive Director John McMillan expressed hope to have medical cannabis available to patients by the end of 2025.

“We need to get our medical certified quickly. All of those things are being arranged as we speak right now, and we’ll see how the winter goes,” Vaughn said. “Hopefully all these things will be implemented fairly quickly.”

Sam Blakemore, a pharmacist and board member, said in an interview after the meeting that medical cannabis can help relieve symptoms without side effects such as nausea and vomiting.

“Everyone focuses on Delta-9, but there are over 120 chemicals in the plant that are able to provide this whole-body experience to allow patients to really get relief when they have nausea and vomiting and spasticity,” Blakemore said.

Blakemore primarily prescribes drugs for pediatric oncology patients. He brought his wife and two young children to the meeting to celebrate the approval of the licenses.

“I’m not going to say that cannabis is a cure, but the most important thing to get that right now is at least people, I call patients and in the state where I close them, they can get relief,” Blakemore said. “They can’t get relief from opioids. They can’t get relief from gabapentin. They might finally be able to try something.”

Supporters of medicinal cannabis attended the meeting on Thursday.

Amanda Taylor, a medical cannabis patient advocate, has been part of the commission’s process since 2021. He has multiple brain and spinal injuries.

“I am very happy today because we are on the point of having a work program,” he said in an interview after the meeting.

This story was first published by the Alabama Reflector.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Building Nevada’s most vertically integrated cannabis operation

Published

on

By

Nevada is one of the most competitive retail cannabis markets in the United States, and Deep Roots Harvest has been betting for years that the way to win is to control everything. 11 cultivation, processing, manufacturing, extraction and retail locations all under one roof, or pretty close to it. Chris O’Ferrell, Deep Roots Harvest’s Chief Cultivator, runs the growing side of that operation in two facilities totaling 30,000 square feet, pushing 500 pounds of harvested cannabis per week and 2,000 pounds of biomass per month.

“The Source and Deep Roots harvest retail team sells 75 kilos of cannabis daily, 500 kilos weekly, over a third of which is in-house to support the High Heads, Neon Moon and CAMP brands. We cultivate, extract, process, manufacture and work the retail locations,” says Chris. “We have one of the largest market shares in Nevada in terms of retail volume and gross sales.”

That volume is produced by 60 full-time employees at the two sites, and the crop program behind it is, by any reasonable measure, built for efficiency and quality. “Many of the genetics in our library consistently exceed 100 grams per square foot, which directly helps reduce our overall cost per gram,” explains Chris. “We operate with a consumer-first approach, focusing on cost consciousness while providing tasty and competitive offerings. We operate below 70 cents per gram, a benchmark that reflects careful cost management. Getting there and staying there has required compressing costs at all input levels while continuing to invest in technology that moves the needle on quality, cost efficiency and performance.”

© Deep Roots Harvest Chris O’Ferrell, Chief Cultivator at Deep Roots Harvest

Genetics as intended by the producer
The transition of light is a clear example of this, as is the case with cannabis. In the beginning, the company used your classic HPS lights. As LED technology advanced, Deep Roots made the switch. However, it wasn’t just about improving energy efficiency. Chris and the team understood that the more precisely the crop was targeted, the better the final product would be. Energy savings don’t necessarily show up on retail shelves, but crop control does, in the form of flowers that express their genetics the way the grower intended.

To achieve this level of control, the spectrum became a critical tool. “We start with the spring setting, using the blue light to regulate the spacing of the interiors and control the spacing,” he explains. “As the plants progress, we move to the summer spectrum until the end of week eight, switching to a broader spectrum light with balanced wavelengths. This increases the red light, along with other parts of the spectrum to more closely replicate sunlight. We also increase the light intensity during the flowering phase to improve the plant’s photosynthetic performance, accumulation and photosynthetic activity. The parameters support the initiation of flowering, accelerate maturation and allow the plant to reach its potential they allow him to fully express his genetics.”

Nothing is left to chance
At canopy level, plants from the two largest facilities are housed in two-gallon coco pots, chosen to accommodate longer growing periods and larger plant structures. The second facility operates stone wool. Both use substrate sensors in connection with fertigation control, and track performance at different growth stages. Dissolved oxygen is injected into the root zone to increase availability, and a chlorine injection system keeps the lines clear of pathogens with a relatively inexpensive cleanup compared to conventional cleaning programs. “A chlorine injection system is relatively inexpensive to implement, replacing approximately $40,000 in other cleaning and disinfection products annually,” says Chris. “It’s all about being ahead of the curve.”

Pest management is entirely biological, implemented in conjunction with mechanical and cultural controls. “We haven’t had any pest problems,” says Chris. “This was also a decision based on reducing inputs while maintaining, if not improving, the quality of the product.”

Genetics is the backbone of cannabis operations and the gas that drives the company’s engine. They receive the same systematic treatment as all other parts of the operation. A steering committee reviews the portfolio quarterly, withdrawing underperforming cultivars and acquiring replacements based on market data from multiple markets, cross-referenced with gaps in the current menu. The criteria are repeatable agronomic performance, yield, potency, distinctive flavor profile and the ability to wash well for extraction, ensuring strong yields for both rosin and resin production. “All genetics need to adapt to the program,” says Chris. “Unique production, potency and flavor expression that fills the void of what we don’t have on the menu. It’s about finding a commercial cultivar that works well and fits the existing infrastructure. All the cultivars we grow now have a similar and predictable growth structure. The difference is the color, the smell, the experience. They are very close agronomically.”

For more information:
Harvest deep roots
deeprootsharvest.com

Continue Reading

Cannabis News

Marijuana Reform Group Polls Consumers About Freedoms Where They Live Ahead Of 4/20

Published

on

By

Ahead of the unofficial cannabis holiday on 4/20, a leading marijuana reform group is asking consumers to take a poll about the freedoms they experience (or lack thereof) where they live.

The new 2026 Cannabis Freedom Survey from the National Organization for Reform of Marijuana Laws (NORML) includes the questions: “Where you live, how free are adults to legally possess and access cannabis?” and “Where you live, how concerned are you about the legal consequences for cannabis users?”

The survey “is designed to capture the real-time sentiment of cannabis consumers in the United States and abroad to see how individuals experience the politics of cannabis in their daily lives,” NORML said.

The the questioning It also includes a question asking people to choose “the most important step that would increase the freedom of cannabis where you live.”

Options include ending marijuana arrests, legalizing adult marijuana, allowing adults to grow their own cannabis, allowing the sale of legal cannabis, making legal cannabis cheaper, clearing records and resolving past convictions, changing federal cannabis laws and protecting consumer rights (parental, workplace, housing, health).

In addition, it asks whether respondents at the national level fully respect marijuana policy for consumer freedom, whether it is moving in the right direction, stagnant without significant progress, or regressing.

“In some jurisdictions, cannabis comes with real freedom. In others, it still comes with real consequences,” NORML Director of Development JM Pedini said in a press release. “This survey is about capturing that gap, not just what the laws say, but how people actually experience them.”

Pedini told Marijuana Moment that the organization will likely compile the results and release them a few days before 4/20.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Governor vetoes medical cannabis bill

Published

on

By











The veto pen is one of the most powerful tools in the Mississippi Legislature, and Governor Tate Reeves has used it throughout his tenure. This year, his vetoes have mostly targeted public health bills so far, with more to come.

There are three ways Reeves could handle the bills that passed both chambers. He can sign bills he supports and allow them to become law without his signature. He can also block legislation he disagrees with by vetoing a bill or part of it and deferring it to a future legislative session.

As of Wednesday, April 8, he has vetoed four bills, half as many as in the previous two sessions, but Reeves will continue to review the legislation and reject more proposals in the coming days.

Reeves vetoed two medical marijuana bills that passed the Legislature this session, dealing a fatal blow to bills that have already faced friendly chambers. One of the bills, the “Right to Try Medical Cannabis,” contained only one specific provision that Reeves disputed. The original intent of the bill, which Reeves praised, was to expand the opportunity to try medical marijuana to those with debilitating conditions that fall outside the scope of current law.

Read more at Clarion Ledger










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media